Hinge Health, Inc. (HNGE) Stock | HNGE Stock Price & Analysis

Feed

HNGE

Hinge Health, Inc. HNGE NYSE · Healthcare · United States

$115.40 -4.62% -$5.59

Summary

68 / 100 · Bulios Score

Valuation 12Growth -Profitability 93Quality 96Debt 89Stability 45

What speaks for it

Out of every 100 USD of revenue, 21 USD is left as net profit.
It earns 45 USD a year on every 100 USD of invested capital.
It holds more cash than debt: $211.6M against $33.9M.
Analysts expect revenue to grow by 50% this fiscal year.

What to watch

The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks expensive

Bulios Fair Price

Overvalued Price today $115.4

By our assumptions the business is worth less than its shares cost today.

P/E today 58.0

Medical - Healthcare Information Services industry median

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 58.0 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

Revenue (USD)

293M

390M

588M

879M

1.1B

20232024202520262027

Diluted EPS (USD)

-$1.39

-$0.15

-$5.19

$2.52

$3.13

20232024202520262027

Analyst estimate

For the next fiscal year analysts expect revenue to grow by 50%.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Cost of sales 14 USD
Research and development 17 USD
Sales and administration 50 USD
Taxes and other -2.3 USD
Net profit 21 USD

Net profit, industry median (Medical - Healthcare Information Services) 5.7 USD

Out of every 100 USD of revenue, 21 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Cash and short-term investments $294.7M

Debt $33.9M

Free cash flow over 12 months $318.7M

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Buy 16
Hold 1
Sell 0

Today's price within the analysts' price targets

Today's price $115.4 Average target $107.15

$76 $140

The average target of $107.15 is 7.1% below today's price. 94% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

Reportable Segment 100%

By region

The company reports no revenue by region.

Reportable Segment brings in 100% of revenue.

Segments in detail